Cargando…

Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies

BACKGROUND: Infection of B-cells with Epstein–Barr virus (EBV) leads to more and subsequent immortalization. This is considered as the method of choice for generating lymphoblastoid cell lines (LCLs). Producing LCLs, although very useful but is very time consuming and troublesome, drives the require...

Descripción completa

Detalles Bibliográficos
Autores principales: Tousizadeh, Behnaz, Moghim, Sharareh, Chaleshtori, Ahmad Reza Salehi, Ghanbarian, Maryam, Mirian, Mina, Salehi, Mansoor, Tousizadeh, Sepideh, Zaboli, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539668/
https://www.ncbi.nlm.nih.gov/pubmed/28808646
http://dx.doi.org/10.4103/2277-9175.210659
_version_ 1783254524354363392
author Tousizadeh, Behnaz
Moghim, Sharareh
Chaleshtori, Ahmad Reza Salehi
Ghanbarian, Maryam
Mirian, Mina
Salehi, Mansoor
Tousizadeh, Sepideh
Zaboli, Fatemeh
author_facet Tousizadeh, Behnaz
Moghim, Sharareh
Chaleshtori, Ahmad Reza Salehi
Ghanbarian, Maryam
Mirian, Mina
Salehi, Mansoor
Tousizadeh, Sepideh
Zaboli, Fatemeh
author_sort Tousizadeh, Behnaz
collection PubMed
description BACKGROUND: Infection of B-cells with Epstein–Barr virus (EBV) leads to more and subsequent immortalization. This is considered as the method of choice for generating lymphoblastoid cell lines (LCLs). Producing LCLs, although very useful but is very time consuming and troublesome, drives the requirement for quicker and more reliable methods for EBV-driven B-cell transformation. MATERIALS AND METHODS: After successfully production of LCLs, different parameters including temperature, serum concentration, type of culture medium, and CO(2) concentration were evaluated on EBV-transformed B-cells. In this study, we were able to produce LCLs and optimize condition. RESULTS: The best condition for generating LCLs was 37°C, 5% CO(2), 20% fasting blood sugar, and RPMI 1640. The study results were to establish a reliable method for producing LCLs that can be used to produce immortalized B-cells from almost any sources. CONCLUSION: This can help with tumorgenecity studies, as well as producing control material for rare genetic disorders and so on. The aim of this study was to determine optimized condition for reliable and reproducible LCLs from different sources.
format Online
Article
Text
id pubmed-5539668
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-55396682017-08-14 Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies Tousizadeh, Behnaz Moghim, Sharareh Chaleshtori, Ahmad Reza Salehi Ghanbarian, Maryam Mirian, Mina Salehi, Mansoor Tousizadeh, Sepideh Zaboli, Fatemeh Adv Biomed Res Original Article BACKGROUND: Infection of B-cells with Epstein–Barr virus (EBV) leads to more and subsequent immortalization. This is considered as the method of choice for generating lymphoblastoid cell lines (LCLs). Producing LCLs, although very useful but is very time consuming and troublesome, drives the requirement for quicker and more reliable methods for EBV-driven B-cell transformation. MATERIALS AND METHODS: After successfully production of LCLs, different parameters including temperature, serum concentration, type of culture medium, and CO(2) concentration were evaluated on EBV-transformed B-cells. In this study, we were able to produce LCLs and optimize condition. RESULTS: The best condition for generating LCLs was 37°C, 5% CO(2), 20% fasting blood sugar, and RPMI 1640. The study results were to establish a reliable method for producing LCLs that can be used to produce immortalized B-cells from almost any sources. CONCLUSION: This can help with tumorgenecity studies, as well as producing control material for rare genetic disorders and so on. The aim of this study was to determine optimized condition for reliable and reproducible LCLs from different sources. Medknow Publications & Media Pvt Ltd 2017-07-14 /pmc/articles/PMC5539668/ /pubmed/28808646 http://dx.doi.org/10.4103/2277-9175.210659 Text en Copyright: © 2017 Advanced Biomedical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Tousizadeh, Behnaz
Moghim, Sharareh
Chaleshtori, Ahmad Reza Salehi
Ghanbarian, Maryam
Mirian, Mina
Salehi, Mansoor
Tousizadeh, Sepideh
Zaboli, Fatemeh
Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies
title Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies
title_full Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies
title_fullStr Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies
title_full_unstemmed Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies
title_short Application of Epstein–Barr Virus for Optimization of Immortalized B-lymphocyte Production as a Positive Control in Genetic Studies
title_sort application of epstein–barr virus for optimization of immortalized b-lymphocyte production as a positive control in genetic studies
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539668/
https://www.ncbi.nlm.nih.gov/pubmed/28808646
http://dx.doi.org/10.4103/2277-9175.210659
work_keys_str_mv AT tousizadehbehnaz applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies
AT moghimsharareh applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies
AT chaleshtoriahmadrezasalehi applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies
AT ghanbarianmaryam applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies
AT mirianmina applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies
AT salehimansoor applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies
AT tousizadehsepideh applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies
AT zabolifatemeh applicationofepsteinbarrvirusforoptimizationofimmortalizedblymphocyteproductionasapositivecontrolingeneticstudies